Reports and Briefs on Pharmaceutical Manufacturers

The following industries match your search criteria:

Published within

« | 1 | 2 | 3 | 4 | » »|

Click here to sort results by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

Alcon Inc.: PharmaVitae Profile

Analysis of Alcon's corporate strategy, marketed portfolio, pipeline potential and financial position in 2009 and to 2015

Published By Datamonitor
16 Dec 2010 $2800
Buy
Report
Report

Allergan Inc.: PharmaVitae Report

Analysis of Allergan's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
09 Dec 2011 $2800
Buy
Report
Report

Apotex Inc.: PharmaVitae Report

Analysis of Apotex's corporate strategy, marketed portfolio and pipeline potential over 2010-2016.

Published By Datamonitor
21 Dec 2011 $2800
Buy
Report
Report

Astellas Pharma Inc.: PharmaVitae Report

Analysis of Astellas's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
02 Sep 2011 $2800
Buy
Report
Report

Bayer AG: Company Analysis

Analysis of Bayer's corporate strategy, marketed portfolio, pipeline potential and financial position in 2011 and to 2017

Published By Datamonitor
08 Aug 2012 $2800
Buy
Report
Report

Boehringer Ingelheim: Company Analysis

Analysis of Boehringer Ingelheim's corporate strategy, marketed portfolio, pipeline potential and financial position in 2011 and to 2017

Published By Datamonitor
26 Oct 2012 $2800
Buy
Report
Report

Bristol-Myers Squibb Co.: Company Analysis

Analysis of BMS's corporate strategy, marketed portfolio, pipeline potential and financial position in 2011 and to 2017

Published By Datamonitor
08 Aug 2012 $2800
Buy
Report
Report

Company Analysis: Johnson & Johnson

Analysis of Johnson & Johnson's corporate strategy, marketed portfolio, pipeline potential, and financial position in 2011 and to 2017.

Published By Datamonitor
17 Dec 2012 $2800
Buy
Report
Report

Daiichi Sankyo Co., Ltd: PharmaVitae Report

Analysis of Daiichi Sankyo's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
27 Jan 2012 $2800
Buy
Report
Report

Dendreon Corporation: PharmaVitae Report

This report analyzes Dendreon's corporate strategy and sales outlook through to 2016, supported by in-depth analysis of the company’s key products and pipeline, driven by patient-based forecasts and key opinion leader interviews.

Published By Datamonitor
27 Jan 2012 $2800
Buy

« | 1 | 2 | 3 | 4 | » »|

No help is available.